BeStock  
Stocks › Biotechnology › VCEL

Vericel VCEL

US equityMarket cap rank #2449BiotechnologyCAR-T Therapy
$57.52 −$0.74 (-1.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $57.52 0.00%
Open$58.11
Prev close$58.26
Day range$57.33 – $59.49
Volume582.3K
Market cap$2.94B
P/E (TTM)89.9
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$85.37M+26.5% YoY
Operating profit$12.19M+253.2% YoY
Net profit$14.16M+179.1% YoY
Diluted EPS$0.27+170.0% YoY
Free cash flow$15.68M-19.4% YoY
Operating cash flow$17.72M

Revenue, last 8 quarters

$75.4MDec '24$52.6MMar '25$63.2MJun '25$67.5MSep '25$92.9MDec '25$68.4MMar '26$77.5MJun '26$85.4MSep '26

Net profit, last 8 quarters

$19.8MDec '24$-11.2MMar '25$-553.0KJun '25$5.1MSep '25$23.2MDec '25$-6.3MMar '26$2.2MJun '26$14.2MSep '26

Diluted EPS by quarter

0.38Dec '24-0.23Mar '25-0.01Jun '250.10Sep '250.45Dec '25-0.12Mar '260.04Jun '260.27Sep '26

Free cash flow by quarter

$8.5MDec '24$-7.6MMar '25$81.0KJun '25$19.5MSep '25$12.8MDec '25$15.1MMar '26$14.3MJun '26$15.7MSep '26

Annual revenue

$124.2MFY20$156.2MFY21$164.4MFY22$197.5MFY23$237.2MFY24$276.3MFY25

Profitability & balance sheet

Gross margin74.5%
Operating margin8.3%
Net margin10.3%
Return on equity9.4%
Return on assets6.9%
Return on invested capital6.5%
Current ratio5.13
Liabilities / assets25.7%
Cash & investments$170.27M
Total debt$76.32M
Net cash (debt)$93.95M
Free cash flow / sales17.9%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • MACI implants, kits, and instruments$67.37M 78.9%
  • Epicel$12.71M 14.9%
  • NexoBrid$5.29M 6.2%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $85.37M $77.46M $68.43M $276.26M $92.92M
Total Operating Revenue $85.37M $77.46M $68.43M $276.26M $92.92M
Cost of Revenue $22.76M $21.06M $19.16M $70.66M $19.79M
Gross Profit $62.61M $56.40M $49.27M $205.60M $73.13M
Operating Expense $50.42M $55.97M $57.33M $194.56M $50.71M
Selling and Admin Expenses $43.54M $48.48M $49.23M $166.99M $43.46M
-Selling & Marketing Expense $25.53M $28.46M – – –
-General & Admin Expense $18.01M $20.02M – – –
Research & Development $6.89M $7.49M $8.10M $27.56M $7.25M
Operating Profit $12.19M $434,000.00 -$8.06M $11.04M $22.42M
Net Non-Operating Interest Income (Expense) $1.99M $1.79M $1.69M $6.38M $1.72M
Non-Operating Interest Income $2.15M $1.95M $1.85M $7.01M $1.89M
Non-Operating Interest Expense $160,000.00 $160,000.00 $160,000.00 $630,000.00 $162,000.00
Other Income (Expense) -$17,000.00 -$22,000.00 $71,000.00 -$44,000.00 -$36,000.00
Other Non-Operating Income (Expenses) -$17,000.00 -$22,000.00 $71,000.00 -$44,000.00 -$36,000.00
Pretax Profit $14.16M $2.21M -$6.30M $17.38M $24.10M
Net Profit $14.16M $2.21M -$6.30M $16.52M $23.24M
Profit from Continuing Operations $14.16M $2.21M -$6.30M $16.52M $23.24M
Net Income to Parent Company $14.16M $2.21M -$6.30M $16.52M $23.24M
Net Income to Common Stockholders $14.16M $2.21M -$6.30M $16.52M $23.24M
Basic EPS $0.28 $0.04 -$0.12 $0.33 $0.46
Diluted EPS $0.27 $0.04 -$0.12 $0.32 $0.45
Tax – – – $859,000.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $517.11M $502.87M $485.63M $487.97M $487.97M
Total Current Assets $280.77M $264.73M $244.06M $247.44M $247.44M
Cash and Cash Equivalents & Short-Term Investments $170.27M $162.46M $145.34M $137.50M $137.50M
-Cash and Cash Equivalents $133.49M $125.36M $109.30M $100.09M $100.09M
-Short Term Investments $36.78M $37.10M $36.05M $37.41M $37.41M
Receivables $81.80M $75.71M $72.38M $84.63M $84.63M
-Accounts Receivable $81.80M $75.71M $72.38M $84.63M $84.63M
Inventory $17.06M $18.38M $18.35M $17.56M $17.56M
Other Current Assets $11.65M $8.18M $7.99M $7.74M $7.74M
Total Non-Current Assets $236.34M $238.14M $241.56M $240.53M $240.53M
Net PPE $165.67M $167.62M $170.52M $173.17M $173.17M
-Gross PPE $204.99M $203.51M $205.18M $204.72M $204.72M
-Accumulated Depreciation -$39.32M -$35.89M -$34.66M -$31.55M -$31.55M
Investments and Advances $65.34M $64.97M $65.28M $61.40M $61.40M
-Available for Sale Securities $65.34M $64.97M $65.28M $61.40M $61.40M
Goodwill and Other Intangible Assets $5.16M $5.31M $5.47M $5.63M $5.63M
-Other Intangible Assets $5.16M $5.31M $5.47M $5.63M $5.63M
Other Non-Current Assets $179,000.00 $233,000.00 $288,000.00 $341,000.00 $341,000.00
Total Liabilities $132.94M $132.83M $129.40M $133.33M $133.33M
Total Current Liabilities $54.72M $52.53M $47.16M $49.15M $49.15M
Payables $19.96M $20.61M $19.01M $15.83M $15.83M
-Accounts Payable $19.96M $20.61M $19.01M $15.83M $15.83M
Current Accrued Expenses $6.14M $6.14M $5.05M $4.97M $4.97M
Short-Term Debt and Capital Lease Obligation $14.37M $14.27M $14.18M $14.09M $14.09M
-Current Capital Lease Obligation $14.37M $14.27M $14.18M $14.09M $14.09M
Total Non-Current Liabilities $78.22M $80.29M $82.24M $84.18M $84.18M
Long Term Debt and Capital Lease Obligation $76.32M $78.38M $80.36M $82.28M $82.28M
-Long Term Capital Lease Obligation $76.32M $78.38M $80.36M $82.28M $82.28M
Other Non-Current Liabilities $1.90M $1.91M $1.88M $1.90M $1.90M
Total Equity $384.17M $370.04M $356.23M $354.64M $354.64M
Stockholders' Equity $384.17M $370.04M $356.23M $354.64M $354.64M
Capital Stock $751.46M $750.80M $739.00M $730.66M $730.66M
-Common Stock $751.46M $750.80M $739.00M $730.66M $730.66M
Retained Earnings -$366.23M -$380.39M -$382.60M -$376.30M -$376.30M
Gains/Losses Not Affecting Retained Earnings -$1.06M -$365,000.00 -$168,000.00 $275,000.00 $275,000.00
Restricted Cash – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $17.72M $16.19M $16.38M $51.91M $15.01M
Net cash flow from continuing operations $17.72M $16.19M $16.38M $51.91M $15.01M
Net Income from Continuing Operations $14.16M $2.21M -$6.30M $16.52M $23.24M
Depreciation & Depletion & Amortization $3.63M $3.62M $3.27M $11.54M $3.09M
Other Non-Cash Items $1.50M $1.46M $1.44M $5.58M $1.41M
Change in Working Capital -$9.31M -$278,000.00 $6.54M -$21.36M -$22.25M
-Change in Receivables -$6.09M -$3.33M $12.25M -$23.26M -$24.21M
-Change in Inventory $1.35M -$183,000.00 -$964,000.00 -$1.23M -$448,000.00
-Change in Payables and Accrued Expense $849,000.00 $5.25M -$2.68M $5.15M $3.68M
-Change in Other Current Assets -$3.47M -$188,000.00 -$246,000.00 -$457,000.00 $262,000.00
-Change in Other Current Liabilities -$1.96M -$1.89M -$1.83M -$2.62M -$1.78M
-Change In Other Working Capital $7,000.00 $58,000.00 $4,000.00 $1.07M $244,000.00
Net cash flow from investing -$2.71M -$2.82M -$4.20M -$43.94M -$16.39M
Net Cash Flow from Continuing Investing Activities -$2.71M -$2.82M -$4.20M -$43.94M -$16.39M
Capital Expenditure -$2.04M -$1.93M -$1.26M -$27.16M -$2.19M
Net Investment Purchase and Sale -$666,000.00 -$888,000.00 -$2.94M -$16.78M -$14.20M
Financing Cash Flow -$6.88M $2.69M -$2.98M $7.07M $1.07M
Net Cash Flow from Continuing Financing Activities -$6.88M $2.69M -$2.98M $7.07M $1.07M
Net Common Stock Issuance -$6.58M $2.86M $1.56M $13.93M $1.26M
Net Other Financing Charges -$302,000.00 -$166,000.00 -$4.54M -$6.86M -$190,000.00
Ending Cash Balance $133.49M $125.36M $109.30M $100.09M $100.09M
Net Change in Cash $8.14M $16.06M $9.20M $15.04M -$311,000.00
Beginning Cash Balance $125.36M $109.30M $100.09M $85.05M $100.40M
Free Cash Flow $15.68M $14.26M $15.13M $24.75M $12.83M
Net Intangibles Purchase and Sale – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on VCEL.

Sign in to join the discussion.

Scroll to Top